The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
AACR-Johnson & Johnson Lung Cancer Innovation Science Grants
The AACR-Johnson & Johnson Lung Cancer Innovation Science Grants represent a joint effort to address the need for promoting and supporting collaborative cancer research in areas that include digital therapeutics and smoking cessation biomarkers/behavioral phenotyping, to bolster our understanding of how lung cancer can be successfully intercepted. Prioritized areas of interest may include: clinical trials that would identify unique high-risk patients for lung cancer and demonstrate sustained efficacy through the measurement of both quit rates, as well as disease-related biomarkers; clinical trials that would identify digital therapeutics focused on smoking avoidance for first-time smokers or for former smokers; these therapeutics may consider the impact of social engagement, gaming, and other content relevant for populations at a risk of starting or resuming their smoking habit. The inclusion of a strategic plan for clinical confirmation of the digital therapeutic study is recommended.
This project must be implemented by a multi-institutional team, composed of Principal Investigators from at least two, but no more than three, different institutions and include a clinical component with an endpoint relevant to improving the detection or treatment of lung cancer. The Grant will provide $1 million in funding for direct and indirect expenses related to each research project over a three-year timeframe.
Deadline: July 19, 2019
At least two, but no more than three, co-applicants from distinct institutions are required. The team will be directed by the Lead Principal Investigator (Lead PI) and include up to two additional co-Principal Investigators (co-PIs). The Lead PI is responsible for the application, disbursement of funds to the various research projects, the conduct of the projects, and progress reporting.
Principal Investigators (PIs) must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or equivalent doctoral degree) in the biomedical sciences or in a field applicable to health science research and not currently be a candidate for a further doctoral or professional degree.
In addition to the co-PIs, the Project Team should also include at least one young investigator (e.g., postdoctoral or clinical research fellow; junior faculty member). While not a co-PI, this young investigator should play a key role in the project.
Applications will be accepted from independent investigators at all levels who are affiliated with an academic, medical, or research institution anywhere in the world.